Vimarsana
Biggest News Aggregation in the World

Nasdaq Admp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Admp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Admp Today - Breaking & Trending Today

Adamis Pharmaceuticals (NASDAQ:ADMP) Earns Sell Rating from Analysts at StockNews.com - Vimarsana News

Adamis Pharmaceuticals (NASDAQ:ADMP) Earns Sell Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Adamis Pharmaceuticals (NASDAQ:ADMP – Free Report) in a report issued on Wednesday morning. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Adamis Pharmaceuticals Price Performance Adamis Pharmaceuticals has a 1 year low of $0.75 and a 1 year high of $26.18. The firm’s 50 day […]

StockNews.com Begins Coverage on Adamis Pharmaceuticals (NASDAQ:ADMP) - Vimarsana News

StockNews.com Begins Coverage on Adamis Pharmaceuticals (NASDAQ:ADMP)

StockNews.com assumed coverage on shares of Adamis Pharmaceuticals (NASDAQ:ADMP – Free Report) in a research report sent to investors on Tuesday morning. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Adamis Pharmaceuticals Stock Performance The stock has a fifty day moving average price of $1.33 and a two-hundred day moving average […]

Source: wkrb13.com
Adamis Pharmaceuticals Co. (NASDAQ:ADMP) Short Interest Update - Vimarsana News

Adamis Pharmaceuticals Co. (NASDAQ:ADMP) Short Interest Update

Adamis Pharmaceuticals Co. (NASDAQ:ADMP – Get Free Report) was the recipient of a significant drop in short interest during the month of August. As of August 15th, there was short interest totalling 98,900 shares, a drop of 67.7% from the July 31st total of 305,900 shares. Based on an average daily volume of 2,080,000 shares, […]

Adamis Pharmaceuticals (NASDAQ:ADMP) Earns Sell Rating from Analysts at StockNews.com - Vimarsana News

Adamis Pharmaceuticals (NASDAQ:ADMP) Earns Sell Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of Adamis Pharmaceuticals (NASDAQ:ADMP – Free Report) in a research note published on Thursday morning. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Adamis Pharmaceuticals Price Performance Adamis Pharmaceuticals stock opened at $0.89 on Thursday. The business’s fifty day moving average is $1.88 and its two-hundred […]

Adamis Pharmaceuticals Announces Closing of $8.0 Million - Vimarsana News

Adamis Pharmaceuticals Announces Closing of $8.0 Million

SAN DIEGO, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today...